Pharmacokinetic Study of 4 mg Nicotine Lozenge.

Clinical trial NCT01669122 · COMPLETED

Trial details

NCT number: NCT01669122
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2012-06-01
Primary completion: 2012-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.